このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Clariane 将来の成長

Future 基準チェック /36

Clariane利益と収益がそれぞれ年間108.7%と5%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に2.9% 1.9%なると予測されています。

主要情報

106.0%

収益成長率

132.8%

EPS成長率

Healthcare 収益成長	20.6%
収益成長率	4.9%
将来の株主資本利益率	2.9%
アナリストカバレッジ	Low
最終更新日	05 Sep 2024

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

DB:KO2 - アナリストの将来予測と過去の財務データ ( )EUR Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	5,832	131	627	909	4
12/31/2025	5,531	94	543	832	4
12/31/2024	5,270	-46	495	754	4
6/30/2024	5,170	-129	570	934	N/A
3/31/2024	5,083	-111	445	869	N/A
12/31/2023	4,996	-92	320	804	N/A
9/30/2023	4,865	-32	244	799	N/A
6/30/2023	4,735	28	168	794	N/A
3/31/2023	4,587	32	204	828	N/A
12/31/2022	4,438	36	239	862	N/A
6/30/2022	4,288	85	348	900	N/A
3/31/2022	4,212	92	330	870	N/A
12/31/2021	4,137	100	311	840	N/A
9/30/2021	4,047	76	279	818	N/A
6/30/2021	3,941	60	243	785	N/A
3/31/2021	3,857	50	259	790	N/A
12/31/2020	3,773	39	275	795	N/A
9/30/2020	3,728	57	310	765	N/A
6/30/2020	3,683	74	346	734	N/A
3/31/2020	3,648	94	393	750	N/A
12/31/2019	3,613	115	439	766	N/A
9/30/2019	3,542	117	352	687	N/A
6/30/2019	3,471	119	264	607	N/A
3/31/2019	3,404	121	188	492	N/A
12/31/2018	3,336	123	113	377	N/A
9/30/2018	3,280	152	139	371	N/A
6/30/2018	3,224	180	165	364	N/A
3/31/2018	3,177	172	N/A	375	N/A
12/31/2017	3,131	163	N/A	385	N/A
9/30/2017	3,091	150	N/A	353	N/A
6/30/2017	3,052	137	N/A	320	N/A
3/31/2017	3,017	134	N/A	314	N/A
12/31/2016	2,981	131	N/A	307	N/A
9/30/2016	2,880	87	N/A	296	N/A
6/30/2016	2,779	42	N/A	284	N/A
3/31/2016	2,676	50	N/A	264	N/A
12/31/2015	2,573	59	N/A	245	N/A
9/30/2015	2,553	77	N/A	271	N/A
6/30/2015	2,533	95	N/A	297	N/A
3/31/2015	2,378	78	N/A	272	N/A
12/31/2014	2,222	61	N/A	247	N/A
9/30/2014	1,938	44	N/A	186	N/A
6/30/2014	1,654	27	N/A	126	N/A
3/31/2014	1,505	28	N/A	122	N/A
12/31/2013	1,356	29	N/A	119	N/A

アナリストによる今後の成長予測

収入対貯蓄率: KO2は今後 3 年間で収益性が向上すると予測されており、これは貯蓄率 ( 0.7% ) よりも高い成長率であると考えられます。

収益対市場: KO2今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: KO2今後 3 年以内に収益を上げることが予想されます。

収益対市場: KO2の収益 ( 5% ) German市場 ( 5.3% ) よりも低い成長が予測されています。

高い収益成長: KO2の収益 ( 5.4% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: KO2の自己資本利益率は、3年後には低くなると予測されています ( 2.9 %)。

Clariane 将来の成長

Future 基準チェック /36

主要情報

今後の成長に関する最新情報

Clariane Se Provides Earnings Guidance for the Full Year 2024; Reiterates Earnings Guidance for the Full Year from 2023 to 2026

Korian Provides Sales Guidance for the Year 2022

Korian Provides Revenue Guidance for the Full Year 2021 and Full Year 2022

Recent updates

Clariane Group Announces Management Changes

Clariane Se Provides Earnings Guidance for the Full Year 2024; Reiterates Earnings Guidance for the Full Year from 2023 to 2026

Now 20% undervalued

Odalys SA acquired Les Essentielles - SARL from Clariane SE (ENXTPA:CLARI).

New minor risk - Shareholder dilution

Clariane SE has filed a Follow-on Equity Offering in the amount of €237.083186 million.

Clariane SE Appoints Sylvia Metayer as Non-Executive Director

Clariane Confirms Rumor of Disposal of HAD/SSIAD Business in France

Full year 2023 earnings released

Elevation Healthcare Properties managed by Elevation Advisors signed an agreement to acquire Berkley Care Group Ltd from Clariane SE (ENXTPA:CLARI) for £207 million.

Investor sentiment improves as stock rises 22%

Investor sentiment deteriorates as stock falls 18%

Investor sentiment improves as stock rises 15%

Clariane SE to Report First Half, 2024 Results on Jul 30, 2024

Investor sentiment deteriorates as stock falls 23%

Investor sentiment deteriorates as stock falls 36%

Clariane SE to Report Fiscal Year 2023 Results on Feb 28, 2024

Investor sentiment deteriorates as stock falls 15%

Now 20% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 16%

First half 2023 earnings released

Clariane Announces Dividend for the Financial Year 2022, Payable on July 13, 2023

Clariane Announces Dividend for the Financial Year 2022, Payable on July 13, 2023

Upcoming dividend of €0.25 per share at 3.3% yield

Now 21% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 21%

Full year 2022 earnings released

Korian (ENXTPA:KORI) acquired Grupo 5 Acción y Gestión Social, S.A. from Corpfin Capital Asesores, S.A., SGEIC and others.

Korian to Report First Half, 2023 Results on Jul 27, 2023

Investor sentiment deteriorated over the past week

First half 2022 earnings released

Korian Appoints Philippe Lévêque as Director and Chairman of the Ethics, Quality and CSR Committee

Upcoming dividend of €0.35 per share

Investor sentiment deteriorated over the past week

High number of new directors

Korian Proposes Dividend

Full year 2021 earnings: Revenues in line with analyst expectations

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Icade Santé SAS completed the acquisition of 2 nursing homes in Le Teilleul and Notre-Dame-de-Sanilhac from Korian (ENXTPA:KORI) for €13 million.

Korian Provides Sales Guidance for the Year 2022

First half 2021 earnings released: EPS €0.31 (vs €0.13 in 1H 2020)

Korian (ENXTPA : KORI) acquired a 90% stake in Santa Croce s.r.l.

Korian in Exclusive Talks to Acquire Osny Psychotherapy Centre in Val d’Oise

Icade Santé SAS acquired One Post-Acute Care Facility and Two Nursing Homes from Korian (ENXTPA:KORI).

Korian (ENXTPA:KORI) completed the acquisition of ITA Mental Health from Magnum Capital Industrial Partners.

Korian Approves Dividend, Payable on July 1, 2021

Upcoming dividend of €0.30 per share

Korian Provides Revenue Guidance for the Full Year 2021 and Full Year 2022

Korian (ENXTPA:KORI) signed an agreement to acquire ITA Mental Health from Magnum Capital Industrial Partners.

Full year 2020 earnings released

Revenue beats expectations

Korian (ENXTPA:KORI) acquired unknown minority stake in Viva Son Group.

New 90-day high: €32.34

Korian Demonstrates the Relevance of its Asset Smart Strategy through a Partnership with BNP Paribas Cardif and EDF Invest

Icade SA (ENXTPA:ICAD) agreed to acquire Four Nursing Homes in France from Korian (ENXTPA:KORI) for €33.5 million.

New 90-day high: €30.78

Korian (ENXTPA:KORI) completed the acquisition of Inicea Groupe from Antin Infrastructure Partners S.A.S.

Korian Signs Development Partnership with Aedifica in the Netherlands

Korian has completed a Follow-on Equity Offering in the amount of €400.250658 million.

Korian to Report First Half, 2021 Results on Jul 29, 2021

New 90-day low: €26.58

Korian to Report Fiscal Year 2020 Results on Feb 24, 2021

Korian (ENXTPA:KORI) reached a non binding deal to acquire Inicea Groupe for €360 million.

New 90-day low: €27.38

Korian Announces Executive Changes

Korian (ENXTPA:KORI) entered into an agreement to acquire Five Facilities near Amsterdam from Ontzorgd Wonen Groep B.V.

New 90-day low - €31.54

Korian (ENXTPA:KORI) acquired Santa Marinella.

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想